Skip to main content

Table 3 Summary of the studies showing an effect of body weight, uric acid, and heart rate variability on the development of complications in patients with diabetes

From: Variability of risk factors and diabetes complications

Risk factor

Type of variability assessed

Short or long term variability

Metrics used

Type of study

Sample size

Significantly associated outcomes

Follow-up length

References

Body weight

Visit-to-visit

Long-term

Average successive variability

Post-hoc analysis of 3 trials

6408

Composite of cardiovascular events

3.9/4/4.9 years

[29]

Post-hoc analysis of trial

10251

MACE, heart failure, death, and microvascular events

3.5 years

[30]

Coefficient of variation

Observational cohort

1319

All-cause mortality in patients > 65 years

10 years

[31]

Uric acid

Visit-to-visit

Long-term

Standard deviation

Retrospective cohort study

10163

eGRF decline

24 months

[36]

Heart rate

24-h ECG Holter, expiration/inspiration (E/I) ratio during deep breathing, acceleration index (AI) of R-R interval in response to head-up tilt

Short-term

Low frequency

Observational cohort

61

Intima-media thickness

8 years

[41]

Supine deep breathing 12-lead electrocardiograms

Short-term

Standard deviation of consecutive RR intervals

Observational cohort

1416

Coronary artery calcium

6.0 ± 0.5 years

[42]

Coefficient of variance for 100 R–R intervals

Observational cohort

8917 (3089 with diabetes)

Sudden cardiac death

5.2 years

[43]

24-h ECG Holter

Short-term

Standard deviation of NN intervals

Observational cohort

240

All-cause mortality

15.5 years

[44]